CRISPR Therapeutics AG (CRSP) is a company based on the NASDAQ exchange with a current stock price of 52.17 USD, after having risen 1.3 USD or 2.5555% in the last 24 hours and with an average volume of 1.05 million shares over the past 10 days. The company currently has a market capitalization of 4 billion USD with earnings per share (EPS) of 3.76 and price-to-earnings ratio (P/E) of 13.88. Its market capitalization on February 1st, 2023 was 4 bln USD, which increased to 4.39 bln USD by February 2nd before dropping again to 4.32 bln USD by the 3rd of February.
CRISPR Therapeutics AG has been performing relatively well compared to its all-time highs and lows, reaching a low of 38.94 USD in January 2021 and a high of 86.95USD in April 2021 from its 50-Day Average Price of 49.03 USD and 200-Day Average Price of 59.95 USD respectively on May 12th, 2023 . The company’s Shares Outstanding is 78 million with an Earnings Announcement date set for November 1st 2022 so investors can expect some news about the company’s financial situation soon enough which could cause the stock price to fluctuate more drastically over the coming months leading up to that date The company looks set to maintain its current course as there have not been any drastic changes in its stock movement over time nor have there been major announcements that could steer speculation further one way or another regarding CRISPR Therapeutics AG’s financial health .
